All lobbying filings
ARNOLD & PORTER KAYE SCHOLER LLP
Lobbying for SPYRE THERAPEUTICS, INC. · Biotechnology company focused on treatments for gastrointestinal and rheumatic diseases.
Filing
Registration
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Nov 17, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Massachusetts
Lobbyists on this filing
1
-
BOBBY MCMILLIN New on this filingPreviously held: General Counsel, Senate Committee on Health, Education, Labor, & Pensions (HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-13); Press Intern, Sen. Chambliss (2007)
Lobbying activity
3
FDA policies relating to monoclonal antibody products.
FDA policies relating to monoclonal antibody products.
FDA policies relating to monoclonal antibody products.